Emma Mueller, Author at The Boomer Esiason Foundation

March 19, 2019

The Boomer Esiason Foundation has released a new video to encourage people to join Team Boomer and run for a cause. Team Boomer is a program that: encourages people with cystic fibrosis to incorporate exercise into their everyday lives; provides an avenue for individual athletes in...

TCU Senior Wins 2010 Rimington Trophy

by Emma Mueller

Boomer Esiason Foundation, CF News

March 19, 2019

Texas Christian University senior Jake Kirkpatrick has been named the recipient of the 2010 Rimington Trophy. The Trophy, named for Boomer Esiason Foundation President David B. Rimington, is awarded annually to the most outstanding center in NCAA Division I-A football. Kirkpatrick was previously a finalist for...

Samsung, Sears and BEF Team Up to Tackle Cystic Fibrosis

by Emma Mueller

Boomer Esiason Foundation, CF News

March 19, 2019

The Boomer Esiason Foundation has joined with Samsung Hope for Children, the national philanthropic initiative of the world's technology leader, and Sears to launch a new social action campaign, "Tackle CF with Boomer Esiason." The new initiative will benefit the former NFL quarterback's foundation, which...

iTunes Offers New App for Jerry Cahill’s CF Podcasts

by Emma Mueller

Boomer Esiason Foundation, CF News

March 19, 2019

The Boomer Esiason Foundation is pleased to announce that the cystic fibrosis podcast series produced by BEF Volunteer Jerry Cahill now is available on your iPhone, iPad or iPod Touch. A new iTunes app made specifically for Jerry’s podcasts offers these features: streaming access to play...

BEF Awards $10,000 Scholarships to Two Student-Athletes

by Emma Mueller

Boomer Esiason Foundation, CF News

March 19, 2019

The Boomer Esiason Foundation has awarded $10,000 scholarships to two college freshmen with cystic fibrosis. In addition to demonstrating academic success, community involvement, financial need and compliance with CF therapies, applicants for the Exercise for Life scholarship are required to keep a running log for 12...

AbbVie and Galapagos to Co-Develop CF Therapies

by Emma Mueller

CF News, Therapies

March 19, 2019

Sep 24, 2013 SOURCE: ABBVIE NORTH CHICAGO, Ill. and MECHELEN, Belgium, Sept. 24, 2013 /PRNewswire/ -- Galapagos NV (Euronext: GLPG) and AbbVie (NYSE: ABBV) announced today that they have entered into a global alliance to discover, develop and commercialize novel potentiator and combination therapies in cystic fibrosis...

Cornerstone Therapeutics Inc. announced it is now actively marketing PERTZYE® in the US

by Emma Mueller

CF News, Therapies

March 19, 2019

SOURCE Cornerstone Therapeutics Initiates PERTZYE(R) (pancrelipase) Sales and Marketing Efforts for the Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis CARY, NC--(Marketwired - Jul 29, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) announced today it is now actively marketing PERTZYE® (pancrelipase) in the U.S. for...

FDA Approves New Powder form of Novartis TOBI

by Emma Mueller

CF Community, CF News, Therapies

March 19, 2019

A dry powder form of the antibiotic TOBI - TOBI Podhaler (tobramycin inhalation powder) - used to treat lung infections caused by the bacteria Pseudomonas aeruginosa has been approved by the US Food and Drug Administration (FDA). People with CF ages six and older who have Pseudomonas aeruginosa and...

PTC Therapeutics Announces Promising Results from Phase 3 Trial of Ataluren

by Emma Mueller

CF News, Therapies

March 19, 2019

Source: Cystic Fibrosis Foundation PTC Therapeutics Inc. recently announced results from a Phase 3 clinical trial of ataluren, a potential oral drug aimed at treating the underlying cause of cystic fibrosis. The 48-week study tested ataluren in people with CF ages six and older who have what...

Progress Made on Cayston® Supply Challenges, CFF Reports

by Emma Mueller

CF Community, CF News, Therapies

March 19, 2019

Source: Cystic Fibrosis Foundation Gilead Sciences Inc. announced this week it has made progress resolving a shortage of its inhaled antibiotic Cayston® that began earlier this year. The company said it expects it will be able to lift the restrictions on the drug’s supply in early...

Author: Emma Mueller

New Team Boomer Video: Why Do You Run?

TCU Senior Wins 2010 Rimington Trophy

Samsung, Sears and BEF Team Up to Tackle Cystic Fibrosis

iTunes Offers New App for Jerry Cahill’s CF Podcasts

BEF Awards $10,000 Scholarships to Two Student-Athletes

AbbVie and Galapagos to Co-Develop CF Therapies

Cornerstone Therapeutics Inc. announced it is now actively marketing PERTZYE® in the US

FDA Approves New Powder form of Novartis TOBI

PTC Therapeutics Announces Promising Results from Phase 3 Trial of Ataluren

Progress Made on Cayston® Supply Challenges, CFF Reports

Never miss an update. Subscribe to our emails!